SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

GT Biopharma Reports Third Quarter 2026 Financial Results

Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026 Phas

GTBP

Related stories